Table 3.
Incidence of hospitalization costs and salvage treatments after recurrence or metastasis before inverse probability of treatment weighting adjustment
|
Parameter
|
ESD, n = 98
|
Surgery, n = 220
|
d-CRT, n = 16
|
| Follow up time | 40.0 (35.0-48.0) | 43.0 (34.0-53.75) | 32.5 (28.3-40.0) |
| Total cost | 25 | 100 | 130 |
| Death toll | 1 (1.0) | 19 (8.6) | 3 (18.8) |
| Recurrence | 4 (4.0) | 3 8(17.3) | 4 (25.0) |
| Salvage measures after recurrence or metastasis | Surgery (n = 3) | Surgery (n = 5) | Neoadjuvant chemo-radiotherapy (n = 1) |
| No treatment (n = 1) | Neoadjuvant radiotherapy (n = 4) | ||
| Neoadjuvant chemotherapy (n = 8) | |||
| Neoadjuvant chemo-radiotherapy (n = 15) | |||
| No treatment (n = 7) |
Data are n (%). d-CRT: Definitive chemoradiotherapy; ESD: Endoscopic submucosal dissection.